Colistin Sulfate is a mixture of sulfates of polypeptide antibiotics active against Gram-negative bacteria including Pseudomonas aeruginosa, Enterobacter aerogenes, Escherichia coli and Klebsiella pneumoniae.
Indication: Used in the treatment of acute infections due to sensitive strains of Gram-negative pathogens.
Application: Administered topically in the treatment of local infections, mainly external ear infections. Often formulated as otic suspensions and solutions.
Product grades |
Non-sterile, non-micronized | ||
Compliance |
Ph. Eur. USP |
||
Manufacturing site |
Xellia Pharmaceuticals ApS, Copenhagen, Denmark |
||
Release site |
Xellia Pharmaceuticals ApS, Copenhagen, Denmark |
||
Site registered |
EU GMP certificate US FDA Other Health Authorities |
||
Regulatory documentation |
EU Drug Master File (DMF) Certificate of Suitability (CEP) US Drug Master File (DMF) Letter of Access (LoA) |
||
Packaging sizes |
|
||
Packaging material |
|
||
Shelf life |
| ||
Storage conditions |
| ||
* BOU = Billions of units.
